[go: up one dir, main page]

BR0314300A - Aplicação de substâncias para a proteção da pele - Google Patents

Aplicação de substâncias para a proteção da pele

Info

Publication number
BR0314300A
BR0314300A BR0314300-7A BR0314300A BR0314300A BR 0314300 A BR0314300 A BR 0314300A BR 0314300 A BR0314300 A BR 0314300A BR 0314300 A BR0314300 A BR 0314300A
Authority
BR
Brazil
Prior art keywords
skin protection
protection substances
substances application
application
skin
Prior art date
Application number
BR0314300-7A
Other languages
English (en)
Inventor
Thomas Gassenmeier
Ruediger Graf
Michael Kock
August Bernd
Roland Kaufmann
Stefan Kippenberger
Manfred Schubert-Zsilavecz
Dieter Steinhilber
Oliver Werz
Original Assignee
Phenion Gmbh & Co Kg
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenion Gmbh & Co Kg, Henkel Kgaa filed Critical Phenion Gmbh & Co Kg
Publication of BR0314300A publication Critical patent/BR0314300A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"APLICAçãO DE SUBSTâNCIAS PARA A PROTEçãO DA PELE". A invenção refere-se à aplicação de pelo menos uma substância, que pode formar um íon dipolar e/ou seus derivados para a proteção da pele Poliferationsrate [%] = taxa de proliferação [%]
BR0314300-7A 2002-09-17 2003-09-09 Aplicação de substâncias para a proteção da pele BR0314300A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10243233A DE10243233A1 (de) 2002-09-17 2002-09-17 Verwendung von Substanzen zum Schutz der Haut
PCT/EP2003/009985 WO2004026295A2 (de) 2002-09-17 2003-09-09 Verwendung von substanzen zum schutz der haut

Publications (1)

Publication Number Publication Date
BR0314300A true BR0314300A (pt) 2005-07-26

Family

ID=32009839

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314300-7A BR0314300A (pt) 2002-09-17 2003-09-09 Aplicação de substâncias para a proteção da pele

Country Status (6)

Country Link
EP (1) EP1539128B1 (pt)
AT (1) ATE408404T1 (pt)
AU (1) AU2003273843A1 (pt)
BR (1) BR0314300A (pt)
DE (2) DE10243233A1 (pt)
WO (1) WO2004026295A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100421660C (zh) * 2003-08-05 2008-10-01 胎盘组织治疗中心 治疗白癜风的组合物
US20090017047A1 (en) * 2004-06-11 2009-01-15 Egon Tech Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
US7704531B2 (en) 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
WO2006103056A2 (de) * 2005-03-30 2006-10-05 Gerhard Sauermann Topisches produkt zur vorbeugung und behandlung von windeldermatitis, enthaltend betaine
FR2885801B1 (fr) * 2005-05-20 2009-01-09 Sothys Paris Soc Par Actions Sa Composition cosmetique
DE102005026034A1 (de) * 2005-06-02 2006-12-07 Beiersdorf Ag Wasserarme kosmetische Zubereitungen enthaltend Kreatin in kristalliner Form
EP1996547A2 (en) 2006-03-17 2008-12-03 Croda, Inc. Amine/amide-functionalized lipophiles
WO2009002913A1 (en) * 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis
FR2961392A1 (fr) * 2010-06-17 2011-12-23 Oreal Utilisation de derives d'acide amine comme agent de traitement de la transpiration humaine ; nouveaux composes ; compositions les contenant
DE102020125873A1 (de) * 2020-10-02 2022-04-07 Dr. Kurt Wolff Gmbh & Co. Kg Zusammensetzung zur Behandlung von Haaren und der Kopfhaut
DE102020125874A1 (de) * 2020-10-02 2022-04-07 Dr. Kurt Wolff Gmbh & Co. Kg Zusammensetzung zur Behandlung von Haaren und der Haut
US20250222020A1 (en) * 2022-04-06 2025-07-10 Dr. Kurt Wolff Gmbh & Co. Kg Oral composition containing dimethylglycine for improving the condition of the hair and scalp
DE102022108329A1 (de) * 2022-04-06 2023-10-12 Dr. Kurt Wolff Gmbh & Co. Kg Zusammensetzung zur Behandlung der Haut
DE102023103403A1 (de) 2023-02-13 2024-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Mundpflegemittel mit Dimethylglycin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066589A (en) * 1975-05-23 1978-01-03 Minnesota Mining And Manufacturing Company Solvent repellent complexes
DE2703964A1 (de) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
IE52977B1 (en) * 1981-11-24 1988-04-27 Pascale Ltd Protective composition for users of cyanoacrylate adhesives
GB8713091D0 (en) * 1987-06-04 1987-07-08 Millrine W P Pharmaceutical compositions
HU208072B (en) * 1990-02-28 1993-08-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for preventing and curing autoimmune diseases and skin affections caused by heat and light radiacion
JPH0948720A (ja) * 1995-08-03 1997-02-18 Shiseido Co Ltd 皮膚外用剤
US6114337A (en) * 1998-11-27 2000-09-05 Pugliese; Peter T. Zwitteronic-fatty acid compounds having anti-inflammatory properties
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
AU1773600A (en) * 1998-12-21 2000-07-12 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
SI1216021T1 (pt) * 1999-09-15 2005-08-31 Bayer Consumer Care Ag
AU2003214719A1 (en) * 2002-03-08 2003-09-22 Universiteit Leiden Use proline and its functional equivalentsfor quenching ros and/ or radicals

Also Published As

Publication number Publication date
EP1539128A2 (de) 2005-06-15
WO2004026295A9 (de) 2004-09-16
DE10243233A1 (de) 2004-04-15
DE50310527D1 (de) 2008-10-30
EP1539128B1 (de) 2008-09-17
WO2004026295A3 (de) 2004-11-11
AU2003273843A8 (en) 2004-04-08
ATE408404T1 (de) 2008-10-15
WO2004026295A2 (de) 2004-04-01
AU2003273843A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
BR0314300A (pt) Aplicação de substâncias para a proteção da pele
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
BR0315023B1 (pt) distribuidor de composição anti-séptica de pele.
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
PT1196410E (pt) Inibidores da replicacao de virus sincicial respiratorio
BRPI0412404A (pt) uso de rapamicina e de derivado da rapamicina para o tratamento da perda óssea
BRPI0916091A2 (pt) "composição destinada à proteção da pele e/ou dos cabelos e uso da combinação de pelo menos um amido gelificante e de partículas de poliamida"
PT2336184E (pt) Administração de agentes para o tratamento da inflamação
BR9802837A (pt) Composição cosmética de proteção contra luz.
KR100984939B9 (ko) 발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
PT1221917E (pt) Dispositivo para ministrar medicamentos
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
PT1354873E (pt) Sal de perindopril e as composicoes farmaceuticas que o contem
PT1282616E (pt) Derivados de hidroxifenil-piperidin-4-ilideno-metil-benzamida para o tratamentoda dor
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
BRPI0312413A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e método de utilização para os mesmos
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
PT1286986E (pt) Derivados de quinolil-piperidin-4-ilideno-metil-benzamida para o tratamento da dor
DE69907538D1 (de) Gewebeschutzmittel gegen Schädlinge
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
NO20034561D0 (no) Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer
MXPA02001755A (es) Dispositivo de proteccion contra la deformacion para conductos.
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
WO2005011663A8 (fr) Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8AANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.